Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Adenocarcinoma, Mucinous × 1 year × Clear all

Status

Sponsor Class

Study Type

Interventional 8 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 604 Neoplasms 570 Prostatic Neoplasms 297 Lung Neoplasms 269 Carcinoma, Non-Small-Cell Lung 241 Colorectal Neoplasms 237 Carcinoma, Hepatocellular 159 Pancreatic Neoplasms 154 Multiple Myeloma 119 Stomach Neoplasms 117 Ovarian Neoplasms 107 Hematologic Neoplasms 104 Melanoma 103 Colonic Neoplasms 103 Brain Neoplasms 97 Urinary Bladder Neoplasms 91 Esophageal Neoplasms 90 Leukemia, Myeloid, Acute 87 Head and Neck Neoplasms 86 Neoplasm Metastasis 82 Lymphoma 82 Uterine Cervical Neoplasms 80 Liver Neoplasms 77 Endometrial Neoplasms 77 Disease 76 Carcinoma, Renal Cell 76 Precursor Cell Lymphoblastic Leukemia-Lymphoma 74 Rectal Neoplasms 69 Leukemia 62 Glioma 59

Interventions

DNA Fingerprinting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05734430 2025-04-18

GAP

Vanderbilt-Ingram Cancer Center

Gastrointestinal

Appendiceal Neoplasms, Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡